A systematic review and meta-analysis for human epidermal growth factor receptor 2 on upper tract urothelial carcinoma patients.

Ye, Jianjun; Liao, Xinyang; Qiu, Yu; Wei, Qiang; Bao, Yige

Ye, Jianjun; Liao, Xinyang; Qiu, Yu; Wei, Qiang; Bao, Yige.

Afiliação

Ye J; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Liao X; West China School of Medicine, Sichuan University, Chengdu, Sichuan, China.
Qiu Y; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wei Q; Department of Thyroid and Breast Surgery, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China.
Bao Y; Department of Urology and Institute of Urology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Tumori ; 110(1): 25-33, 2024 Feb.

Article em En | MEDLINE | ID: mdl-37555322

Assuntos

Carcinoma de Células de Transição; Receptor ErbB-2; Neoplasias da Bexiga Urinária; Humanos; Carcinoma de Células de Transição/patologia; Prognóstico; Intervalo Livre de Progressão; Estudos Retrospectivos

Palavras-chave

Her2; clinical outcomes; pathological characters; upper urinary tract urothelial carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição / Receptor ErbB-2 Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google